{"id":"https://openalex.org/W2000659418","doi":"https://doi.org/10.1586/14760584.6.5.723","title":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","display_name":"GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives","publication_year":2007,"publication_date":"2007-10-01","ids":{"openalex":"https://openalex.org/W2000659418","doi":"https://doi.org/10.1586/14760584.6.5.723","mag":"2000659418","pmid":"https://pubmed.ncbi.nlm.nih.gov/17931153"},"language":"en","primary_location":{"id":"doi:10.1586/14760584.6.5.723","doi":"https://doi.org/10.1586/14760584.6.5.723","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14760584.6.5.723","pdf_url":null,"source":{"id":"https://openalex.org/S163950488","display_name":"Expert Review of Vaccines","issn_l":"1476-0584","issn":["1476-0584","1744-8395"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Vaccines","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000659418"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051008333","display_name":"Nathalie Gar\u00e7on","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Nathalie Gar\u00e7on","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Research & Development, Rue de l\u2019Institut 89, 1330 Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Research & Development, Rue de l\u2019Institut 89, 1330 Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029032645","display_name":"Patrick Chomez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Patrick Chomez","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Research & Development, Rue de l\u2019Institut 89, 1330 Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Research & Development, Rue de l\u2019Institut 89, 1330 Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103481388","display_name":"Marcelle Van Mechelen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095529","display_name":"GlaxoSmithKline (Belgium)","ror":"https://ror.org/00n3pea85","country_code":"BE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210095529"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marcelle Van Mechelen","raw_affiliation_strings":["GlaxoSmithKline Biologicals, Research & Development, Rue de l\u2019Institut 89, 1330 Rixensart, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline Biologicals, Research & Development, Rue de l\u2019Institut 89, 1330 Rixensart, Belgium","institution_ids":["https://openalex.org/I4210095529"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210095529"],"apc_list":null,"apc_paid":null,"fwci":2.1759,"has_fulltext":false,"cited_by_count":479,"citation_normalized_percentile":{"value":0.90342679,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"6","issue":"5","first_page":"723","last_page":"739"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9814000129699707,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.016100000590085983,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protein-subunit-vaccines","display_name":"subunit vaccine","score":0.6959999799728394},{"id":"https://openalex.org/keywords/recombinant-antigen","display_name":"recombinant antigen","score":0.7990000247955322},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.5339999794960022},{"id":"https://openalex.org/keywords/innate-immune-activation","display_name":"innate immune activation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/prophylactic-vaccines","display_name":"prophylactic vaccines","score":0.847000002861023},{"id":"https://openalex.org/keywords/therapeutic-vaccines","display_name":"therapeutic vaccines","score":0.9950000047683716},{"id":"https://openalex.org/keywords/viral-vaccines","display_name":"viral vaccines","score":0.7059999704360962},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.7419999837875366}],"concepts":[{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.9356446266174316},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.8101290464401245},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6232330799102783},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6126688718795776},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5528676509857178},{"id":"https://openalex.org/C3020289777","wikidata":"https://www.wikidata.org/wiki/Q967453","display_name":"Vaccine adjuvant","level":3,"score":0.47424808144569397},{"id":"https://openalex.org/C193419808","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired immune system","level":3,"score":0.4556451737880707},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4471386969089508},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3540083169937134},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000277","descriptor_name":"Adjuvants, Pharmaceutic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000536","descriptor_name":"Aluminum Hydroxide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008050","descriptor_name":"Lipid A","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008050","descriptor_name":"Lipid A","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008288","descriptor_name":"Malaria","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008288","descriptor_name":"Malaria","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D012503","descriptor_name":"Saponins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014612","descriptor_name":"Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014612","descriptor_name":"Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014777","descriptor_name":"Virus Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014777","descriptor_name":"Virus Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1586/14760584.6.5.723","doi":"https://doi.org/10.1586/14760584.6.5.723","is_oa":false,"landing_page_url":"https://doi.org/10.1586/14760584.6.5.723","pdf_url":null,"source":{"id":"https://openalex.org/S163950488","display_name":"Expert Review of Vaccines","issn_l":"1476-0584","issn":["1476-0584","1744-8395"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320449","host_organization_name":"Informa","host_organization_lineage":["https://openalex.org/P4310320449"],"host_organization_lineage_names":["Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Vaccines","raw_type":"journal-article"},{"id":"pmid:17931153","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17931153","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of vaccines","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":82,"referenced_works":["https://openalex.org/W146717125","https://openalex.org/W161238046","https://openalex.org/W1517693128","https://openalex.org/W1582232949","https://openalex.org/W1601065475","https://openalex.org/W1666510860","https://openalex.org/W1857197615","https://openalex.org/W1894593978","https://openalex.org/W1897355343","https://openalex.org/W1965519620","https://openalex.org/W1967600699","https://openalex.org/W1973196190","https://openalex.org/W1975633275","https://openalex.org/W1976689988","https://openalex.org/W1986605614","https://openalex.org/W1991203808","https://openalex.org/W1998462329","https://openalex.org/W1999861975","https://openalex.org/W2000695993","https://openalex.org/W2001831020","https://openalex.org/W2002298962","https://openalex.org/W2006097708","https://openalex.org/W2007669051","https://openalex.org/W2009522572","https://openalex.org/W2018354452","https://openalex.org/W2019840235","https://openalex.org/W2022863293","https://openalex.org/W2027388819","https://openalex.org/W2028513578","https://openalex.org/W2036767516","https://openalex.org/W2038907536","https://openalex.org/W2038910210","https://openalex.org/W2045279869","https://openalex.org/W2047770044","https://openalex.org/W2050871684","https://openalex.org/W2050922850","https://openalex.org/W2053233981","https://openalex.org/W2058916344","https://openalex.org/W2062690077","https://openalex.org/W2063755565","https://openalex.org/W2067448602","https://openalex.org/W2071279865","https://openalex.org/W2074122062","https://openalex.org/W2075477269","https://openalex.org/W2077539073","https://openalex.org/W2077844467","https://openalex.org/W2080537910","https://openalex.org/W2084409666","https://openalex.org/W2086404290","https://openalex.org/W2086747066","https://openalex.org/W2095065953","https://openalex.org/W2098491904","https://openalex.org/W2106024548","https://openalex.org/W2106528225","https://openalex.org/W2106781193","https://openalex.org/W2112969654","https://openalex.org/W2113802001","https://openalex.org/W2114813165","https://openalex.org/W2120627680","https://openalex.org/W2123643891","https://openalex.org/W2123817481","https://openalex.org/W2127436087","https://openalex.org/W2129200532","https://openalex.org/W2131967743","https://openalex.org/W2139533311","https://openalex.org/W2143895770","https://openalex.org/W2150436558","https://openalex.org/W2151784087","https://openalex.org/W2153991907","https://openalex.org/W2154567574","https://openalex.org/W2154933177","https://openalex.org/W2155144810","https://openalex.org/W2156255370","https://openalex.org/W2157427941","https://openalex.org/W2157889559","https://openalex.org/W2158614517","https://openalex.org/W2159831861","https://openalex.org/W2166720811","https://openalex.org/W2207867951","https://openalex.org/W2319526973","https://openalex.org/W2340524139","https://openalex.org/W2903491901"],"related_works":["https://openalex.org/W1987154487","https://openalex.org/W2282117713","https://openalex.org/W3144140615","https://openalex.org/W2090259541","https://openalex.org/W2885768754","https://openalex.org/W2579566490","https://openalex.org/W2968330413","https://openalex.org/W2150508940","https://openalex.org/W2088002180","https://openalex.org/W1990994812"],"abstract_inverted_index":{"The":[0],"need":[1],"for":[2,21,104,132],"potentiating":[3],"immune":[4,54,61,114,146],"responses":[5],"to":[6,16,41,96,140],"recombinant":[7],"or":[8],"subunit":[9],"antigens":[10],"has":[11,69,101],"prompted":[12],"GlaxoSmithKline":[13],"(GSK)":[14],"Biologicals":[15],"develop":[17],"various":[18,87],"Adjuvant":[19,29,66,81,128],"Systems":[20,30,129],"the":[22,42,45,51,107,119,125,141,145],"design":[23],"of":[24,33,109,127,135,148],"prophylactic":[25],"and":[26,44,56,130,144],"therapeutic":[27],"vaccines.":[28],"are":[31],"formulations":[32],"classical":[34],"adjuvants":[35],"mixed":[36],"with":[37],"immunomodulators,":[38],"specifically":[39],"adapted":[40,139],"antigen":[43],"target":[46,142],"population.":[47],"They":[48],"can":[49],"activate":[50],"appropriate":[52],"innate":[53],"system":[55],"subsequently":[57],"impact":[58],"on":[59],"adaptive":[60],"responses.":[62],"AS04":[63],"is":[64,83,94,116],"an":[65],"System":[67],"that":[68],"demonstrated":[70],"significant":[71],"achievements":[72],"in":[73,86],"several":[74],"vaccines":[75,105],"against":[76],"viral":[77],"diseases.":[78],"AS02,":[79],"another":[80],"System,":[82],"being":[84],"evaluated":[85],"contexts,":[88],"where":[89,106],"a":[90,110],"strong":[91],"T-cell":[92],"response":[93,115],"needed":[95],"afford":[97],"protection.":[98,149],"Likewise,":[99],"AS01":[100],"been":[102],"developed":[103],"induction":[108],"yet":[111],"stronger":[112],"T-cell-mediated":[113],"required.":[117],"Altogether,":[118],"promising":[120],"clinical":[121],"results":[122],"strongly":[123],"support":[124],"concept":[126],"allow":[131],"further":[133],"development":[134],"new":[136],"vaccines,":[137],"best":[138],"population":[143],"mechanisms":[147]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":16},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":24},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":24},{"year":2019,"cited_by_count":29},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":30},{"year":2016,"cited_by_count":32},{"year":2015,"cited_by_count":24},{"year":2014,"cited_by_count":30},{"year":2013,"cited_by_count":32},{"year":2012,"cited_by_count":33}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}